Cargando…
320. Differentiating Dengue from COVID-19: A Diagnostic Challenge in the Tropical Regions of the Americas
BACKGROUND: The differentiation between dengue and coronavirus disease 2019 (COVID-19) diagnoses is a challenge in tropical regions due to the similarity of symptoms and limited access to specific diagnostic tests for each disease. The objective of this study was to describe the initial symptoms and...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644879/ http://dx.doi.org/10.1093/ofid/ofab466.522 |
_version_ | 1784610188242714624 |
---|---|
author | Rosso, Fernando Rojas, Olga Lucia agudelo |
author_facet | Rosso, Fernando Rojas, Olga Lucia agudelo |
author_sort | Rosso, Fernando |
collection | PubMed |
description | BACKGROUND: The differentiation between dengue and coronavirus disease 2019 (COVID-19) diagnoses is a challenge in tropical regions due to the similarity of symptoms and limited access to specific diagnostic tests for each disease. The objective of this study was to describe the initial symptoms and laboratory test values of patients who presented to the emergency department with dengue or COVID-19. A cross-sectional study was performed in a single center in Cali, Colombia METHODS: The inclusion criteria were patients with a diagnosis of dengue or COVID-19 who were older than 14 years of age. All patients experienced fever or other symptoms for fewer than ten days. Linear regression was performed to evaluate the differences in the neutrophil-lymphocyte ratio (NLR) between patients diagnosed with COVID-19 and dengue and was adjusted for sex and age group (≤31 and >31 years). The sample size was calculated to test the hypothesis that the median NLR in COVID-19 patients is higher than that in dengue patients. A p-value < 0.05 was considered statistically significant for all analyses RESULTS: A total of 93 patients were included: 70 with dengue and 23 with COVID-19. Dengue patients were younger than COVID-19 patients. There were significant differences between dengue and COVID-19 patients regarding platelet count (p< 0.01), neutrophil count (p< 0.01), neutrophil-lymphocyte ratio (NLR) (p< 0.01), and abnormal alanine transaminase (ALT) (p=0.03). The NLR was significantly higher in COVID-19 patients than in dengue patients (p< 0.01). Table 1. Demographics, clinical and laboratory characteristics in COVID-19 and dengue patients. [Image: see text] CONCLUSION: In conclusion, during the first week of symptoms, absolute neutrophil count, NLR, and platelet count could help guide the initial differential approach between dengue and COVID-19. These findings could be useful in geographical areas with a lack of resources. DISCLOSURES: All Authors: No reported disclosures |
format | Online Article Text |
id | pubmed-8644879 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-86448792021-12-06 320. Differentiating Dengue from COVID-19: A Diagnostic Challenge in the Tropical Regions of the Americas Rosso, Fernando Rojas, Olga Lucia agudelo Open Forum Infect Dis Poster Abstracts BACKGROUND: The differentiation between dengue and coronavirus disease 2019 (COVID-19) diagnoses is a challenge in tropical regions due to the similarity of symptoms and limited access to specific diagnostic tests for each disease. The objective of this study was to describe the initial symptoms and laboratory test values of patients who presented to the emergency department with dengue or COVID-19. A cross-sectional study was performed in a single center in Cali, Colombia METHODS: The inclusion criteria were patients with a diagnosis of dengue or COVID-19 who were older than 14 years of age. All patients experienced fever or other symptoms for fewer than ten days. Linear regression was performed to evaluate the differences in the neutrophil-lymphocyte ratio (NLR) between patients diagnosed with COVID-19 and dengue and was adjusted for sex and age group (≤31 and >31 years). The sample size was calculated to test the hypothesis that the median NLR in COVID-19 patients is higher than that in dengue patients. A p-value < 0.05 was considered statistically significant for all analyses RESULTS: A total of 93 patients were included: 70 with dengue and 23 with COVID-19. Dengue patients were younger than COVID-19 patients. There were significant differences between dengue and COVID-19 patients regarding platelet count (p< 0.01), neutrophil count (p< 0.01), neutrophil-lymphocyte ratio (NLR) (p< 0.01), and abnormal alanine transaminase (ALT) (p=0.03). The NLR was significantly higher in COVID-19 patients than in dengue patients (p< 0.01). Table 1. Demographics, clinical and laboratory characteristics in COVID-19 and dengue patients. [Image: see text] CONCLUSION: In conclusion, during the first week of symptoms, absolute neutrophil count, NLR, and platelet count could help guide the initial differential approach between dengue and COVID-19. These findings could be useful in geographical areas with a lack of resources. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2021-12-04 /pmc/articles/PMC8644879/ http://dx.doi.org/10.1093/ofid/ofab466.522 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Poster Abstracts Rosso, Fernando Rojas, Olga Lucia agudelo 320. Differentiating Dengue from COVID-19: A Diagnostic Challenge in the Tropical Regions of the Americas |
title | 320. Differentiating Dengue from COVID-19: A Diagnostic Challenge in the Tropical Regions of the Americas |
title_full | 320. Differentiating Dengue from COVID-19: A Diagnostic Challenge in the Tropical Regions of the Americas |
title_fullStr | 320. Differentiating Dengue from COVID-19: A Diagnostic Challenge in the Tropical Regions of the Americas |
title_full_unstemmed | 320. Differentiating Dengue from COVID-19: A Diagnostic Challenge in the Tropical Regions of the Americas |
title_short | 320. Differentiating Dengue from COVID-19: A Diagnostic Challenge in the Tropical Regions of the Americas |
title_sort | 320. differentiating dengue from covid-19: a diagnostic challenge in the tropical regions of the americas |
topic | Poster Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644879/ http://dx.doi.org/10.1093/ofid/ofab466.522 |
work_keys_str_mv | AT rossofernando 320differentiatingdenguefromcovid19adiagnosticchallengeinthetropicalregionsoftheamericas AT rojasolgaluciaagudelo 320differentiatingdenguefromcovid19adiagnosticchallengeinthetropicalregionsoftheamericas |